Bob, you are right of course, but it is hard to really see SOL as a diversified investment house with a history of 'steady as she goes', suddenly take on the qualities that drove CSL as a highly focused leading niche operator in the market of plasma and blood products.
Bob, you are right of course, but it is hard to really see SOL...
Add SOL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$34.80 |
Change
-0.180(0.51%) |
Mkt cap ! $12.41B | |||
| Open | High | Low | Value | Volume |
| $34.94 | $34.95 | $34.58 | $10.87M | 312.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1378 | $34.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $34.80 | 249 | 1 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| SOL (ASX) Chart |
